Overview

A Study of Eszopiclone in Subjects With Insomnia Related to Major Depressive Disorder

Status:
Completed
Trial end date:
2004-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate subjective sleep efficacy in subjects with insomnia related to major depressive disorder.
Phase:
Phase 3
Details
Lead Sponsor:
Sunovion
Treatments:
Eszopiclone